Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Taro SaitoDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama Funabashi, Chiba 274-8510, Japan.
Mahiru SuzukiDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama Funabashi, Chiba 274-8510, Japan.
Aiko OhbaDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama Funabashi, Chiba 274-8510, Japan.
Shogo HamaguchiDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama Funabashi, Chiba 274-8510, Japan.
Iyuki NamekataDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama Funabashi, Chiba 274-8510, Japan.
Hikaru TanakaDepartment of Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama Funabashi, Chiba 274-8510, Japan.
Funding
JSPS KAKENHI JP2016013JSPS KAKENHI JP20K07091JSPS KAKENHI JP20K07299Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan N-231501
6 · The paper itself
Abstract
The effects of enhanced late I
Indexed as
CalciumCnidarian VenomsMyocytes, CardiacPulmonary VeinsSodium-Calcium ExchangerAction PotentialsAniline CompoundsAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingCyclic AMP-Dependent Protein KinasesGuinea PigsIsoquinolinesMalePhenyl EthersSodiumAniline CompoundsCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Cnidarian VenomsCyclic AMP-Dependent Protein KinasesIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamidePhenyl EthersSEA 0400SodiumSodium-Calcium ExchangerSodium ChannelsSulfonamidestoxin II (Anemonia sulcata)automaticityCa2+ overloadintracellular Na+late INaNa+/Ca2+ exchangerpulmonary vein cardiomyocytes
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.